TABLE 6.
Action | [Pyr1]Apelin-13 | Apelin-13 | Apelin-36 | ||||||
---|---|---|---|---|---|---|---|---|---|
EC50 | pD2 | EMAX | EC50 | pD2 | EMAX | EC50 | pD2 | EMAX | |
Inotropya | 0.1 | 9.9 ± 0.2 | 49% | 0.08 | 10.1 ± 0.3 | 64% | 0.04 | 10.4 ± 0.2 | 39% |
Vasodilatationb | 1.6 | 8.8 ± 0.1 | 39% | 0.6 | 9.2 ± 0.2 | 51% | 0.8 | 9.1 ± 0.2 | 43% |
Vasoconstrictionc | 1.6 | 8.8 ± 0.5 | 30% | 0.8 | 9.1 ± 0.2 | 19% | 0.6 | 9.2 ± 0.5 | 17% |
EC50, the concentration (nmol/l) of apelin peptide producing 50% of the maximum response to that peptide; EMAX, maximum response, expressed as a % of a reference stimulus; pD2, negative log10 EC50.
Human, electrically paced atrial strip. Maximum response is % inotropic response to calcium (8.95 mmol/l).
Endothelium-dependent vasodilatation in human mammary artery pre-constricted with ET-1. Maximum response (EMAX) is % reversal of ET-1 response.
Contraction of endothelium-denuded saphenous vein. Maximum response (EMAX) is %KCL (100 mmol/l). Tissues were maintained in organ baths at 37°C in oxygenated physiologic saline (Maguire et al., 2009).